RxDoctor Payments Data

Mark Harwood, MD

Clinical Cardiac Electrophysiology · Spokane, WANPI 1356559975

Payments from drug & device makers

What this record shows

Abbott accounts for 81.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $1,659 and has fallen 92.4% since, to $125 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in WA, where the typical reported total is $7,912.

$3,382in general payments, 2019–2025

Across 35 payments — averaging $96.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Biosense Webster, Inc.$312
  • Boston Scientific$135
  • Impulse Dynamics (USA) Inc.$76
  • Cardiva Medical, Inc.$52
  • Medtronic$45
$49,695in research payments, 2019–2025

Across 38 payments — averaging $1307.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Atricure, Inc.$32K
  • Medtronic$18K

What the payments were for

  • Travel & lodging$2,01760%
  • Food & beverage$1,36540%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,382 in reported general payments places this provider in the 30th percentile of 68 clinical cardiac electrophysiology providers in Washington.

See all clinical cardiac electrophysiology providers in Washington

Medicare billing

Part B allowed, 2024
$378,762
Medicare patients
1,956
Services billed
6,473

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban409$497,396
XareltoRivaroxaban201$183,929
JardianceEmpagliflozin60$66,963
MultaqDronedarone Hcl11$27,943
EntrestoSacubitril/Valsartan14$21,004
Flecainide Acetate383$15,613
PradaxaDabigatran Etexilate Mesylate34$8,980
Metoprolol Succinate510$8,386
Dofetilide33$6,243
Digoxin78$4,019
Dabigatran EtexilateDabigatran Etexilate Mesylate14$3,004
Dilt-XrDiltiazem Hcl70$2,906
Propafenone Hcl51$2,797
Diltiazem 24hr Er (Cd)Diltiazem Hcl108$2,493
Potassium Chloride120$2,324

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Spokane

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →